Stock TLX TELIX PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Telix Pharmaceuticals Limited

Equities

TLX

AU000000TLX2

Market Closed - Australian S.E.
Other stock markets
 02:10:44 2024-04-26 am EDT 		5-day change 1st Jan Change
14.91 AUD +0.20% Intraday chart for Telix Pharmaceuticals Limited +9.55% +47.92%
Apr. 18 Jarden Adjusts Telix Pharmaceuticals Price Target to AU$13.52 from AU$13.27, Keeps at Buy MT
Apr. 17 Telix Pharmaceuticals Limited Reports Unaudited Revenue Results for the First Quarter Ended 31 March 2024 CI

Evolution of the average Target Price on Telix Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

54210df3693fa.jJjfXJJZnvko0r1EwCFLhDUP4dpVT7zAnnfB-9qQbiM.6uKQM6Id65FOte4X8nkO9nZjgrU9CYSP8y_wnpb3Pmu835Ur4Br6oGfjyg~ac1981f10f90f65a1f1854e3e7271d0c

Analyst Recommendations on Telix Pharmaceuticals Limited

Jarden Adjusts Telix Pharmaceuticals Price Target to AU$13.52 from AU$13.27, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
14.88 AUD
Average target price
15.29 AUD
Spread / Average Target
+2.75%
High Price Target
19.3 AUD
Spread / Highest target
+29.70%
Low Price Target
13.52 AUD
Spread / Lowest Target
-9.14%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Telix Pharmaceuticals Limited

Jarden Research

Ratings for Telix Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. TLX Stock
  4. Consensus Telix Pharmaceuticals Limited